Eli Lilly & Co. is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The company reported first-quarter financial results and said demand for its weight-loss drugs, including Zepbound, and for diabetes-drug Mounjaro were strong. The company plans to expand manufacturing capacity to meet demand, The Wall Street Journal reported. Dow Jones & Co. owns Factiva.